Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 1.19% | 178.18 | 1.3% | $463.63m | |
| CELG | Celgene Corporation | 0.86% | 97.34 | 1.3% | $421.72m | |
| GILD | Gilead Sciences, Inc. | 1.27% | 67.20 | 0.9% | $393.42m | |
| BIIB | Biogen Inc. | 2.10% | 232.44 | 1.3% | $354.81m | |
| ILMN | Illumina, Inc. | 0.92% | 347.18 | 3.5% | $270.42m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.69% | 310.41 | 2.6% | $232.86m | |
| A | Agilent Technologies, Inc. | -0.03% | 69.95 | 1.6% | $212.01m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.57% | 172.89 | 1.9% | $197.23m | |
| ARRY | Array BioPharma Inc. | 55.20% | 45.93 | 8.2% | $184.00m | |
| EXAS | Exact Sciences Corporation | 0.27% | 110.08 | 25.3% | $183.38m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.40% | 120.76 | 2.0% | $176.29m | |
| BMRN | BioMarin Pharmaceutical Inc. | 4.08% | 84.14 | 4.3% | $136.15m | |
| MRTX | Mirati Therapeutics Inc. | 6.23% | 100.13 | 2.5% | $113.68m | |
| IONS | Ionis Pharmaceuticals, Inc. | 3.51% | 64.27 | 8.2% | $96.36m | |
| INCY | Incyte Corporation | 4.81% | 81.45 | 2.5% | $91.50m |
Company Profile
Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.